首页 > 市场调查报告书 > 医疗设备

体外诊断癌症

2030 年亚太地区肺癌筛检市场预测 - 区域分析 - 按癌症类型、技术、年龄层（50 岁及以上和 50 岁以下）和最终用户（医院、诊断中心等）

市场调查报告书

商品编码

1402525

2030 年亚太地区肺癌筛检市场预测 - 区域分析 - 按癌症类型、技术、年龄层（50 岁及以上和 50 岁以下）和最终用户（医院、诊断中心等）

Asia Pacific Lung Cancer Screening Market Forecast to 2030 - Regional Analysis - by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

出版日期: 2023年11月01日 | 出版商:

The Insight Partners | 英文 132 Pages | 订单完成后即时交付

价格

简介目录图表

亚太地区肺癌筛检市场预计将从2022年的7.112亿美元成长到2030年的13.6243亿美元。预计2022年至2030年CAGR为8.5%。

结构化肺癌筛检计画推动亚太肺癌筛检市场

一些国家面临肺癌筛检计画的挑战。以人口为基础的澳洲筛检计画的一些例子包括「BreastScreen」、「国家肠癌筛检计画」和「全国子宫颈筛检计画」。

RIVM 人口筛检中心 (RIVM-CvB) 代表卫生部领导和管理国家人口筛检计画；根据该计划，所有荷兰公民都被邀请在生命中的某个阶段参加国家筛检计划。纽约州启动、设立并资助三个癌症族群筛检计画。

因此，对结构良好的计划至关重要，例如社区为基础的计划或临床医生和潜在参与者之间共享的、知情的决策计划；经认可的报告中心；以及用于品质控制、监测和结果报告的中央资料登记处。此外，综合戒烟干预、支持成本效益的国际资料、额外的死亡率福利和高可持续性率是肺癌筛检必须研究的几个因素。此外，国际肺癌研究协会建议在不参与肺癌筛检研究的亚太国家实施可行性筛检计画。这些计划包括戒烟措施、用于选择和管理筛选参与者的标准化演算法，以及管理具有积极筛检结果的参与者的专业多学科团队。因此，在预测期内，实施结构化肺癌筛检计画预计将成为肺癌筛检市场的一个利润丰厚的机会。

亚太地区肺癌筛检市场概况

亚太地区肺癌筛检市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。该地区的增长归因于多种因素，例如肺癌发病率的增加和人们吸烟率的增加。此外，政府对筛检的支持不断增加，导致市场进一步成长。

亚太地区肺癌筛检市场2030年营收及预测（百万美元）

亚太地区肺癌筛检市场细分

亚太地区肺癌筛检市场按癌症类型、技术、年龄层、最终用户和国家细分。

根据癌症类型，亚太地区肺癌筛检市场分为非小细胞肺癌（NSCLC）和小细胞肺癌。 2022年，非小细胞肺癌（NSCLC）细分市场在亚太地区肺癌筛检市场中占据更大份额。

根据技术，亚太地区肺癌筛检市场分为胸部X光检查、低剂量电脑断层扫描（LDCT）、液体切片等。 2022年，胸部X光检查在亚太地区肺癌筛检市场中占据最大份额。

根据年龄组，亚太地区肺癌筛检市场分为50岁及以上及50岁以下。2022年，50岁及以上细分市场在亚太地区肺癌筛检市场中占有较大份额。

根据最终用户，亚太地区肺癌筛检市场分为医院、诊断中心等。 2022年，医院细分市场在亚太地区肺癌筛检市场中占据最大份额。

依国家划分，亚太地区肺癌筛检市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2022年，中国在亚太地区肺癌筛检市场占据主导地位。

Intelerad Medical Systems Incorporated、Nuance Communications Inc、GE HealthCare Technologies Inc、Medtronic Plc、佳能医疗系统公司、皇家飞利浦 NV 和西门子 AG 是亚太地区肺癌筛检市场上的一些领先公司。

研究范围
Insight Partners 研究报告指南
市场区隔
- 亚太地区肺癌筛检市场 - 按技术分类
- 亚太地区肺癌筛检市场 - 按癌症类型
- 亚太地区肺癌筛检市场 - 按年龄组
- 亚太地区肺癌筛检市场 - 按最终用户划分
- 亚太地区肺癌筛检市场 - 按国家/地区

第 2 章：亚太地区肺癌筛检市场 - 要点

第 3 章：研究方法

覆盖范围
二次研究
初步研究

第 4 章：亚太地区肺癌筛检市场 - 市场格局

概述
亚太地区 PEST 分析
专家意见

第 5 章：亚太地区肺癌筛检市场 - 主要市场动态

市场驱动因素
- 肺癌发生率上升
- 增加政府支持
市场限制
- 肺癌筛检测试成本高昂
市场机会
- 结构化肺癌筛检计划
未来的趋势
- 移动式肺癌筛检车
影响分析

第 6 章：亚太地区肺癌筛检市场 - 亚太地区分析

亚太地区肺癌筛检市场收入预测与分析

第 7 章：亚太地区肺癌筛检市场 - 2028 年收入和预测 - 按癌症类型

概述
2022 年及 2030 年亚太地区肺癌筛检市场收入份额，依癌症类型划分（%）
非小细胞肺癌 (NSCLC)
小细胞肺癌

第 8 章：亚太地区肺癌筛检市场分析 - 按技术

概述
低剂量电脑断层扫描 (LDCT)
胸部X光检查
液体活检
其他的

第 9 章：亚太地区肺癌筛检市场分析 - 按年龄组

概述
及较旧的
50以下

第 10 章：亚太地区肺癌筛检市场分析 - 按最终用户

概述
医院
诊断中心
其他的

第 11 章：亚太地区肺癌筛检市场 - 收入和 2028 年预测 - 国家分析

亚太肺癌筛检市场

第 12 章：亚太地区肺癌筛检市场-产业格局

近期成长策略
- 概述

第 13 章：公司简介

Intelerad Medical Systems
Nuance Communications Inc
GE HealthCare
Medtronic
Canon Inc.
Koninklijke Philips NV
Siemens AG

第 14 章：附录

关于 Insight Partners
专业术语

简介目录图表

Product Code: BMIRE00029045

The Asia Pacific lung cancer screening market is expected to grow from US$ 711.20 million in 2022 to US$ 1,362.43 million by 2030. It is estimated to grow at a CAGR of 8.5% from 2022 to 2030.

Structured Lung Cancer Screening Program Fuel Asia Pacific lung Cancer Screening Market

Several countries face challenges with lung cancer screening programs. A few examples of population-based Australian screening programs are "BreastScreen," the "National Bowel Cancer Screening Program," and the "National Cervical Screening Program."

On behalf of the Ministry of Health, the RIVM Center for Population Screening (RIVM-CvB) leads and manages the National Population Screening Programme; under which all Dutch citizens are invited, at a certain point in their lives, to participate in one of the national screening programs. The State begins, sets up, and finances three cancer population screening programs.

Therefore, there is a crucial requirement for a well-structured program such as a community-based program or a shared, informed decision-making program between clinicians and potential participants; accredited reporting centers; and a central data registry for quality control, monitoring, and outcome reporting. Additionally, integrated smoking cessation intervention, international data supporting cost-effectiveness, additional mortality benefits, and a high sustainability rate are a few factors that must be studied for lung cancer screening. Further, the International Association for the Study of Lung Cancer recommends implementing feasibility screening programs in the countries of Asia Pacific without participating in lung cancer screening studies. These programs involve smoking cessation initiatives, standardized algorithms for selecting and managing screening participants, and specialist multidisciplinary teams to manage participants with positive screening results. Therefore, the implementation of structured lung cancer screening programs is expected to be a lucrative opportunity in the lung cancer screening market during the forecast period.

Asia Pacific Lung Cancer Screening Market Overview

The Asia Pacific lung cancer screening market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The regional growth is attributed to various factors, such as the increasing incidence of lung cancer and growing prevalence of cigarette smoking among people. Also, rising government support for screening has led to the further growth of the market.

Asia Pacific lung cancer screening market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Lung Cancer Screening Market Segmentation

The Asia Pacific lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.

Based on cancer type, the Asia Pacific lung cancer screening market is segmented into Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer. The non-small cell lung cancer (NSCLC) segment held a larger share of the Asia Pacific lung cancer screening market in 2022.

Based on technology, the Asia Pacific lung cancer screening market is segmented into chest x-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Chest x-ray segment held the largest share of the Asia Pacific lung cancer screening market in 2022.

Based on age group, the Asia Pacific lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the Asia Pacific lung cancer screening market in 2022.

Based on end user, the Asia Pacific lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the Asia Pacific lung cancer screening market in 2022.

Based on country, the Asia Pacific Lung Cancer Screening Market is segmented into China Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific lung cancer screening market in 2022.

Intelerad Medical Systems Incorporated, Nuance Communications Inc, GE HealthCare Technologies Inc, Medtronic Plc, Canon Medical Systems Corp, Koninklijke Philips NV, and Siemens AG are some of the leading companies operating in the Asia Pacific lung cancer screening market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Lung Cancer Screening Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific Lung Cancer Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Asia Pacific Lung Cancer Screening Market - by Technology
- 1.3.2 Asia Pacific Lung Cancer Screening Market - by Cancer Type
- 1.3.3 Asia Pacific Lung Cancer Screening Market - by Age Group
- 1.3.4 Asia Pacific Lung Cancer Screening Market - by End User
- 1.3.5 Asia Pacific Lung Cancer Screening Market - by Country

2. Asia Pacific Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Lung Cancer Screening Market - Market Landscape

4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert's Opinion

5. Asia Pacific Lung Cancer Screening Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Lung Cancer Incidences
- 5.1.2 Increasing Government Support
5.2 Market Restraints
- 5.2.1 High Cost of Lung Cancer Screening Tests
5.3 Market Opportunities
- 5.3.1 Structured Lung Cancer Screening Program
5.4 Future Trends
- 5.4.1 Mobile Lung Cancer Screening Truck
5.5 Impact Analysis

6. Asia Pacific Lung Cancer Screening Market - Asia Pacific Analysis

6.1 Asia Pacific Lung Cancer Screening Market Revenue Forecast and Analysis

7. Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

7.1 Overview
7.2 Asia Pacific Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non-Small Cell Lung Cancer (NSCLC)
- 7.3.1 Overview
- 7.3.2 Non-Small Cell Lung Cancer (NSCLC): Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
- 7.4.1 Overview
- 7.4.2 Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Lung Cancer Screening Market Analysis - by Technology

8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
- 8.2.1 Overview
- 8.2.2 Low-Dose Computed Tomography (LDCT): Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
- 8.3.1 Overview
- 8.3.2 Chest X-ray: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
- 8.4.1 Overview
- 8.4.2 Liquid Biopsy: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Lung Cancer Screening Market Analysis - by Age Group

9.1 Overview
9.2 & Older
- 9.2.1 Overview
- 9.2.2 & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
- 9.3.1 Overview
- 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Lung Cancer Screening Market Analysis - by End User

10.1 Overview
10.2 Hospitals
- 10.2.1 Overview
- 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2028 - Country Analysis

11.1 Asia Pacific Lung Cancer Screening Market

12. Asia Pacific Lung Cancer Screening Market-Industry Landscape

12.1 Recent Growth Strategies
- 12.1.1 Overview

13. Company Profiles

13.1 Intelerad Medical Systems
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Nuance Communications Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 GE HealthCare
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Medtronic
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Canon Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Koninklijke Philips NV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Siemens AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. China: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 2. China: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. Japan: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 6. Japan: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. India: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 10. India: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Australia: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 14. Australia: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. South Korea: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 18. South Korea: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 22. Rest of Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. Recent Growth Strategies in the Asia Pacific Lung Cancer Screening Market
Table 26. Glossary of Terms

List Of Figures

Figure 1. Asia Pacific Lung Cancer Screening Market Segmentation
Figure 2. Asia Pacific Lung Cancer Screening Market, by Country
Figure 3. Asia Pacific Lung Cancer Screening Market Overview
Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Asia Pacific Lung Cancer Screening Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Asia Pacific Lung Cancer Screening Market Impact Analysis of Driver and Restraints
Figure 9. Asia Pacific Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
Figure 10. Asia Pacific Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
Figure 11. Non-Small Cell Lung Cancer (NSCLC): Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Asia Pacific Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 14. Low-Dose Computed Tomography (LDCT): Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 15. Chest X-ray: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 16. Liquid Biopsy: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 19. 50 & Older: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Asia Pacific Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 22. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 26. Asia Pacific Lung Cancer Screening Market Revenue Share, by Country, 2022 & 2030 (%)
Figure 27. China: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Japan: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. India: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Australia: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. South Korea: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)